| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/28/1999 | US5958457 Compositions for the delivery of antigens |
| 09/28/1999 | US5958456 Comprising drug, sustained release excipient, and diluent; for oral administration |
| 09/28/1999 | US5958452 Sustained release formulation comprising extruded blend of drug, hydrophobic material, hydrophobic fusible carrier divided into unit dose |
| 09/28/1999 | US5958445 Organoleptically acceptable antiinflammatory agent;veterinary drug; for oral administration |
| 09/28/1999 | US5958434 Stable gelled water in oil emulsion and its use in the cosmetic, dermatological, veterinary and/or farm produce fields |
| 09/28/1999 | US5958431 Emulsifying fatty alcohol with at least one from group of glucose, fructose, dextrose, saccharose, galactose, maltose, maltotriose, dextrane, lactose, talose, allose, xylose, levoglucosane, cellusose and starch under acidic conditions |
| 09/28/1999 | US5958412 Administering conjugate of antibody and anti-cancer drug, where in antibody is specific for a33 antigen for promoting colon or gastric cancer regression |
| 09/28/1999 | US5958408 Glycosylation of lysin residue of a clearing agent which is an antibody or an antigen binding fragment of an antibody with a galactose residue for achieving fast clearance |
| 09/28/1999 | US5958398 Biodegradable polyacetal polymers and methods for their formation and use |
| 09/28/1999 | US5958377 Methods of delivering gases to gas-depleted environments |
| 09/28/1999 | US5957848 Preparation of further diagnostic agents |
| 09/28/1999 | CA2133503C Orally administrable opioid formulations having extended duration of effect |
| 09/26/1999 | CA2264323A1 W/h emulsion, composition comprising such an emulsion and its cosmetic, pharmaceutical or hygienic uses |
| 09/26/1999 | CA2264310A1 O/w emulsion, composition comprising such an emulsion and its use in cosmetic, pharmaceutical and hygiene applications |
| 09/23/1999 | WO1999047588A1 Production of microparticles |
| 09/23/1999 | WO1999047176A2 Latent reactive blood compatible agents |
| 09/23/1999 | WO1999047175A1 Pharmaceutical compositions containing melatonin inclusion complexes |
| 09/23/1999 | WO1999047174A1 Amorphous glasses for stabilising sensitive products |
| 09/23/1999 | WO1999047173A2 Carrier for in vivo delivery of a therapeutic agent |
| 09/23/1999 | WO1999047172A2 Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes |
| 09/23/1999 | WO1999047168A2 Induction and enhancement of the immune response to type-2 t cell-independent antigens conjugated to lipid or lipid-containing moieties |
| 09/23/1999 | WO1999047160A1 Stabilized aqueous peptide solutions |
| 09/23/1999 | WO1999047143A1 Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 09/23/1999 | WO1999047140A1 Topical antiseptic compositions and methods |
| 09/23/1999 | WO1999047139A1 Sulfurpenta fluorophenyl pyrazoles for controlling ectoparasitic infestations |
| 09/23/1999 | WO1999047135A1 Conjugated linoleic acid compositions |
| 09/23/1999 | WO1999047130A1 Nanoparticles, method for producing nanoparticles and use of the same |
| 09/23/1999 | WO1999047129A1 Crosslinkable macromers bearing initiator groups |
| 09/23/1999 | WO1999047127A1 Hydrophilic and hydrophobic polyether polyurethanes and uses therefor |
| 09/23/1999 | WO1999047126A1 Polymer based rapidly dissolving tablets and production processes thereof |
| 09/23/1999 | WO1999047124A1 Tablets quickly disintegrating in the oral cavity and process for producing the same |
| 09/23/1999 | WO1999047123A1 Pharmaceutical composition containing a statin and aspirin |
| 09/23/1999 | WO1999047120A1 Ophthalmic solution comprising glycogen |
| 09/23/1999 | WO1999047073A1 Liquid polymeric compositions for controlled release of bioactive substances |
| 09/23/1999 | WO1999047072A1 Hydrophilic polyether polyurethanes containing carboxylic acid |
| 09/23/1999 | WO1999040944A3 Hydroxylation activated drug release |
| 09/23/1999 | WO1999040112A8 Neuroprotective peptides and uses thereof |
| 09/23/1999 | WO1999039740A8 Sensitizing cells to compounds using lipid-mediated gene and compound delivery |
| 09/23/1999 | WO1999039694A3 Compositions containing organic compounds |
| 09/23/1999 | WO1999039692A3 Pharmaceutical compositions in form of polymeric microparticles obtained by extrusion and spheronization |
| 09/23/1999 | WO1999038821A3 Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications |
| 09/23/1999 | WO1999037273A3 Cosmetic and dermatological preparations containing higher electrolyte concentrations |
| 09/23/1999 | WO1999036570A3 Transglutaminase linkage of agents to tissue |
| 09/23/1999 | WO1999036100A3 Polymeric carrier |
| 09/23/1999 | WO1999030727A9 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| 09/23/1999 | WO1999029304A9 Method for high supercoiled dna content microspheres |
| 09/23/1999 | WO1999027944A9 Prevention and treatment of amyloidogenic disease |
| 09/23/1999 | DE19812152A1 Verwendung von polymerisierten Fettsäurederivaten und Fettalkoholderivaten als Solubilisatoren Use of polymerized fatty acid derivatives and fatty alcohol derivatives as solubilizers |
| 09/23/1999 | DE19811919A1 New copolymer of unsaturated carboxylic acid with ester or amide, used as solubilizer, especially for pharmaceutical or cosmetic preparations |
| 09/23/1999 | CA2324235A1 Production of microparticles |
| 09/23/1999 | CA2323784A1 Carrier for in vivo delivery of a therapeutic agent |
| 09/23/1999 | CA2322994A1 Topical antiseptic compositions and methods |
| 09/22/1999 | EP0943341A1 Procedure to prepare granulated compositions that contain erythromycin macrolides and procedure to prepare pharmaceutical compositions that contain said macrolides |
| 09/22/1999 | EP0943340A1 Use of polymerised fatty acid and fatty alcohol derivatives as solubilisers |
| 09/22/1999 | EP0943336A1 Peptide-containing pharmaceutical compositions for oral administration |
| 09/22/1999 | EP0943333A1 Medicament for the prevention and/or treatment of breast cancer comprising an inhibitor of estrogen synthesis |
| 09/22/1999 | EP0943331A2 Formulations containing oxaliplatin |
| 09/22/1999 | EP0942996A1 Thrombolytic agents with antithrombotic activity |
| 09/22/1999 | EP0942986A1 Systems for determining substances active against hpv-associated diseases |
| 09/22/1999 | EP0942780A1 Coated particles, methods of making and using |
| 09/22/1999 | EP0942754A2 Conjugates useful in the treatment of prostate cancer |
| 09/22/1999 | EP0942743A1 Topical preparation for introducing peptidaceous pharmacons in living organisms |
| 09/22/1999 | EP0942738A1 Polyethylene glycol esters of polyunsaturated fatty acids |
| 09/22/1999 | EP0942736A1 Methods of prevention and treatment of ischemic damage |
| 09/22/1999 | EP0942724A2 Gel formulations for topical drug delivery |
| 09/22/1999 | EP0942721A1 Pharmaceutical composition |
| 09/22/1999 | EP0942716A1 Composition for transdermal delivery of drugs |
| 09/22/1999 | EP0942697A1 Fatty acid esters of lactic acid salts as permeation enhancers |
| 09/22/1999 | EP0804223B1 Hgh containing pharmaceutical compositions |
| 09/22/1999 | EP0726764B1 Multilamellar liposomal arachidonic acid metabolite formulations |
| 09/22/1999 | EP0653931B1 Industrial, pharmaceutical and cosmetic applications for cultured plant cell gums |
| 09/22/1999 | EP0620741B1 Cytotoxic drug therapy |
| 09/22/1999 | CN1229436A Antigen binding fragments that specifically detect cancer cells, nucleotindes encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 09/22/1999 | CN1229355A Pharmaceutical aerosol composition |
| 09/22/1999 | CN1228994A Pharmaceutical composition of hedgehog proteins and use thereof |
| 09/22/1999 | CN1228962A Composition and methods using nitroxides to avoid oxygen toxicity |
| 09/22/1999 | CN1228937A Use of carotenoid aggregates as colorants |
| 09/21/1999 | US5955603 Porphyrins and porphyrin synthesis techniques |
| 09/21/1999 | US5955585 Catalytic condensation method for the preparation of chlorophyll and bacteriochlorophyll derivatives |
| 09/21/1999 | US5955584 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 09/21/1999 | US5955578 Synthetic matrix of synthetic polypeptide including amino acid sequence of d-arginine-glycine-aspartic acid, a biodegradable polymer, and optional crosslinking agent; temporary wound healing agent which promotes cell migration |
| 09/21/1999 | US5955503 Modified amino acid compounds useful as carriers in the delivery of biologically active agents such as, for example, bioactive peptides and the like |
| 09/21/1999 | US5955502 Use of fatty acid esters as bioadhesive substances |
| 09/21/1999 | US5955475 Salt formation to anhydrate; vacuum evaporation of solvent; water solubility |
| 09/21/1999 | US5955467 Pharmaceutical formulations of poorly water soluble camptothecin analogues and NMP |
| 09/21/1999 | US5955457 Water soluble rapamycin esters |
| 09/21/1999 | US5955456 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol |
| 09/21/1999 | US5955454 Nasal pharmaceutical composition containing a progestogen |
| 09/21/1999 | US5955452 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments |
| 09/21/1999 | US5955451 Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein |
| 09/21/1999 | US5955449 Diagnosis and treatment of bacterial dysentery |
| 09/21/1999 | US5955448 Method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
| 09/21/1999 | US5955442 Methods for treating respiratory disease |
| 09/21/1999 | US5955439 Inhalant includes antiasthmatic agent and fluorocarbon propellant; low ozone depletion potential |
| 09/21/1999 | US5955434 N-terminal fmoc-protected peptide combinations that form gels in water |
| 09/21/1999 | US5955430 Use of angiotensin II fragments and analogs thereof in tissue repair |
| 09/21/1999 | US5955427 Pharmaceutical composition |
| 09/21/1999 | US5955365 Introducing polynucleotides into cells |
| 09/21/1999 | US5955108 Cross-linked microparticles and their use as therapeutic vehicles |
| 09/21/1999 | US5955106 Hydrocolloid-forming agent as a retardant |